Skip to content

Quantedge Capital Pte Ltd: ADNT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Quantedge Capital Pte Ltd on ADNT, newest first. How the timeline and the estimate are built.

Quantedge Capital Pte Ltd held 408,111 ADNT shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 408,111 shares
    Change vs previous 13F +16,900 shares

    5.69% of the 13F portfolio, value $7,501,080.

    13F-HR 0001561418-26-000011 filed by Quantedge Capital Pte Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 391,211 shares
    Change vs previous 13F -377,200 shares

    4.32% of the 13F portfolio, value $7,906,374.

    13F-HR 0001561418-26-000008 filed by Quantedge Capital Pte Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 768,411 shares
    Change vs previous 13F -291,700 shares

    7.02% of the 13F portfolio, value $14,730,439.

    13F-HR 0001172661-26-001044 filed by Quantedge Capital Pte Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,060,111 shares
    Change vs previous 13F +1,036,111 shares

    13.97% of the 13F portfolio, value $25,527,473.

    13F-HR 0001172661-25-004877 filed by Quantedge Capital Pte Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 24,000 shares
    Change vs previous 13F not available

    0.43% of the 13F portfolio, value $467,040.

    13F-HR 0001172661-25-003307 filed by Quantedge Capital Pte Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).